Burns and the use of silver sulphadiazine.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002056:Burns / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D003365:Costs and Cost Analysis; D004755:Enterobacteriaceae / Q000302:isolation & purification; D013293:Enterococcus faecalis / Q000302:isolation & purification; D004926:Escherichia coli / Q000302:isolation & purification; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007709:Klebsiella / Q000302:isolation & purification; D008297:Male; D008875:Middle Aged; D009824:Ointments; D011549:Pseudomonas / Q000302:isolation & purification; D011552:Pseudomonas Infections / Q000517:prevention & control; D012835:Silver Nitrate / Q000627:therapeutic use*; D013210:Staphylococcus / Q000302:isolation & purification; D013411:Sulfadiazine / Q000627:therapeutic use*; D014946:Wound Infection / Q000517:prevention & control
D009824:Ointments; D013411:Sulfadiazine; D012835:Silver Nitrate